Sign in

CIK 0001386570

  • Large accelerated filer

Niagen Bioscience, Inc.

Sign in to watch
Ticker
NAGE
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262940963
Phone
+1 310-388-6706
Business address
10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
Former names
ChromaDex Corp., CODY RESOURCES, INC.
  1. 5 Insider Annual Insider Trading Report
  2. 4 Open-market buy CEO bought 10,000 shares at $3.09 ($30,900)
  3. 4 Open-market buy CEO bought 2,500 shares at $4.03 ($10,075)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy CEO bought 2,253 shares at $4.43 ($9,981)
  11. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,900 shares at $3.85 ($26,565)
  12. 4 Open-market buy CEO bought 5,000 shares at $3.80 ($19,000)
  13. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,725 shares at $3.99 ($26,833)
  14. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 7,300 shares at $3.62 ($26,426)
  15. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 5,700 shares at $3.49 ($19,893)
  16. 4 Open-market sale EXECUTIVE CHAIRMAN OF BOARD sold 14,390 shares at $3.50 ($50,365)
  17. 4 Open-market sale Director sold 10,000 shares at $3.52 ($35,200)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 20 · 384 filings